We have some concerns about Acurx Pharmaceuticals’ (NASDAQ:ACXP) cash burn rate. The company’s spending is higher than its incoming cash flow, which could lead to financial difficulties in the future. It’s important for investors to keep an eye on this trend and monitor the company’s financial health closely.
Subscribe
Login
0 Comments